跳至主要内容
临床试验/IRCT20191027045256N1
IRCT20191027045256N1已完成3 期

Comparison of the effect of treatment with omeprazole and es-omeprazole in reflux disease (GERD) infants Lesser than one year old

Kashan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 month 至 11 months(—)
性别
All

入选标准

  • Infants 1 to 11 months of age with clinical diagnosis of reflux based on symptoms or endoscopic evidence

排除标准

  • Using a PPI in the last 7 days
  • Treatment for reflux symptoms, including histamine 2 receptor antagonists, procinetics, and bismuth-containing antacids within 24 hours before intervention
  • Patients with active gastrointestinal bleeding, apnea, allergic gastroenteritis, eosinophilic gastroenteritis, bleeding disorders, pyloric stenosis, active seizure disorder, acute pancreatitis or meningitis

研究者

相似试验

effect of omeprazole and es-omeprazole in reflux... | 临床试验